Skip to main content

#151721

Anti-CD70 [TAN 1-7] mAb

Cat. #151721

Anti-CD70 [TAN 1-7] mAb

Cat. #: 151721

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD70

Class: Monoclonal

Application: ELISA ; FACS ; IF ; Fn

Reactivity: Mouse

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Southampton

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD70 [TAN 1-7] mAb
  • Alternate name: CD7 Molecule; Tumor Necrosis Factor Ligand Superfamily Member 7; CD27 Ligand; CD27LG; TNFSF7; CD27L; Tumor Necrosis Factor Ligand 8A; Surface Antigen CD7; Ki-24 Antigen; CD7 Antigen; TNLG8A
  • Research fields: Apoptosis and autophagy;Cancer;Immunology;Stem cell biology
  • Clone: TAN 1-7
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Mouse
  • Host: Rat
  • Application: ELISA ; FACS ; IF ; Fn
  • Description: Monoclonal antibody directed against CD70 cytokine, capable of blocking the CD70-CD27 interaction involved in B and T cell activation.
  • Immunogen: Recombinant mouse CD70 (extracellular domain, aa residues 41-195)
  • Immunogen uniprot id: O55237
  • Isotype: IgG2a
  • Myeloma used: NS0
  • Recommended controls: Activated dendritic cells

Target Details

  • Target: CD70
  • Tissue cell line specificity: Activated dendritic cells
  • Target background: CD70 is a cytokine that belongs to the tumour necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes and dendritic cells. It induces proliferation of co-stimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B cell activation, cytotoxic function of natural killer cells, and immunoglobulin synthesis. CD70 expression is induced upon activation of DCs, indicating that the CD70-CD27 interaction could take place during the activation of naive T cells by DCs. Anti-CD70 is non-depleting and blocks the CD70-CD27 interaction. CD70 expression is thought to play a role in autoimmune disease regulation, and treatment of autoimmune diseases such as rheumatoid arthritis.

Applications

  • Application: ELISA ; FACS ; IF ; Fn

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Dry ice

References

  • Arora et al. 2014. Immunity. 40(1):105-16. PMID: 24412610.
  • A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens.
  • Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells.
  • Taraban et al. 2008. J Immunol. 180(7):4615-20. PMID: 18354184.
  • Rowley et al. 2004. J Immunol. 172(10):6039-46. PMID: 15128787.
  • Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.